|
|
| | DIHYDROCODEINE TRIFLUOROACETATE Basic information |
| Product Name: | DIHYDROCODEINE TRIFLUOROACETATE | | Synonyms: | 4,5-alpha-epoxy-3-methoxy-17-methyl-morphinan-6-alpha-o;4,5alpha-Epoxy-3-methoxy-17-methylmorphinan-6alpha-ol;6-alpha-hydrocodol;6alpha-Hydrocodol;6-Hydroxy-3-methoxy-N-methyl-4,5-epoxymorphinan;7,8-dihydro-codein;7,8-Dihydrocodeine;8,14-Dihydroneopine | | CAS: | 125-28-0 | | MF: | C20H24F3NO4 | | MW: | 399.4 | | EINECS: | 204-732-3 | | Product Categories: | | | Mol File: | 125-28-0.mol |  |
| | DIHYDROCODEINE TRIFLUOROACETATE Chemical Properties |
| | DIHYDROCODEINE TRIFLUOROACETATE Usage And Synthesis |
| Description | Dihydrocodeine (Item No. 37884) is an analytical reference standard categorized as an opioid.1 Dihydrocodeine is an active metabolite of hydrocodone (Item Nos. ISO60144 | 15461 | 22166).2 Formulations containing dihydrocodeine have been used in the treatment of severe pain and have been associated with misuse and polypharmacy-related overdose.3 Dihydrocodeine is regulated as a Schedule II compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | | Originator | Bicodein,Uquifa | | Definition | ChEBI: Dihydrocodeine is a morphinane alkaloid. | | Manufacturing Process | The codein was reduced by hydrogen in the presence catalyst Pt (or Pd, or Ni)
and 7,8-dihydrocodein was obtained.
To the 7,8-dihydrocodein tartaric acid was added and mixed, in the result 7,8-
dihydrocodein bitartrate was obtained. | | Therapeutic Function | Antitussive, Narcotic analgesic | | Safety Profile | Poison by ingestion,
intravenous, and subcutaneous routes.
Human systemic effects by ingestion and
subcutaneous routes: somnolence, miosis
(pupillary constriction), and respiratory
depression. An analgesic. Can cause drug
dependency with repeated doses. When
heated to decomposition it emits toxic
fumes of NOx. See also CODEINE. |
| | DIHYDROCODEINE TRIFLUOROACETATE Preparation Products And Raw materials |
|